Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PSMB2 inhibitors(proteasome 20S subunit beta 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H52N4O7 |
InChIKeyIJXUVRJYZJRYCL-BGPVXCRASA-N |
CAS Registry1838705-22-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Netherlands | 18 Jan 2019 | |
Infection by Trypanosoma brucei brucei | Preclinical | United Kingdom | 13 Nov 2018 |